223 related articles for article (PubMed ID: 19923997)
21. [A Case of Liver Metastasis of Descending Colon Cancer with a Pathological Complete Response to mFOLFOX6].
Kawamoto Y; Ome Y; Koda Y; Saga K; Kawamoto K; Ito T
Gan To Kagaku Ryoho; 2016 Jan; 43(1):125-8. PubMed ID: 26809540
[TBL] [Abstract][Full Text] [Related]
22. Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.
Park KJ; Bramlage MP; Ellenson LH; Pirog EC
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):8-11. PubMed ID: 18776815
[TBL] [Abstract][Full Text] [Related]
23. Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions.
Varadhachary GR; Raber MN; Matamoros A; Abbruzzese JL
Lancet Oncol; 2008 Jun; 9(6):596-9. PubMed ID: 18510991
[TBL] [Abstract][Full Text] [Related]
24. [Gastrointestinal metastasis from a primary adenocarcinoma of the lung presenting with acute abdominal pain].
Hsing CT; Kim HY; Lee JH; Han JS; Lee JH; Chang JS; Choi SR; Jeong JS
Korean J Gastroenterol; 2012 May; 59(5):382-5. PubMed ID: 22617534
[TBL] [Abstract][Full Text] [Related]
25. Characterization and applications of a newly developed rabbit monoclonal antibody to cytokeratin 7 (CK7) for immunohistochemistry.
Qi W; Chu J; Zhou D; Tacha D
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):233-8. PubMed ID: 19098679
[TBL] [Abstract][Full Text] [Related]
26. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
Tot T
Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
Chang YY; Lin JK; Jiang JK
Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
[No Abstract] [Full Text] [Related]
28. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
Saad RS; Cho P; Silverman JF; Liu Y
Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary intestinal-type adenocarcinoma.
Maeda R; Isowa N; Onuma H; Miura H
Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):349-51. PubMed ID: 18184677
[TBL] [Abstract][Full Text] [Related]
31. Safety distance in the resection of colorectal lung metastases: a prospective evaluation of satellite tumor cells with immunohistochemistry.
Welter S; Theegarten D; Trarbach T; Maletzki F; Stamatis G; Tötsch M
J Thorac Cardiovasc Surg; 2011 May; 141(5):1218-22. PubMed ID: 21163502
[TBL] [Abstract][Full Text] [Related]
32. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Osunkoya AO; Epstein JI
Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
[TBL] [Abstract][Full Text] [Related]
33. CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.
Saad RS; Silverman JF; Khalifa MA; Rowsell C
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):196-201. PubMed ID: 19098678
[TBL] [Abstract][Full Text] [Related]
34. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
[TBL] [Abstract][Full Text] [Related]
35. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
Groisman GM; Meir A; Sabo E
Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
[TBL] [Abstract][Full Text] [Related]
36. [A case of advanced colon cancer responding to treatment with levofolinate combined with 5-fluorouracil].
Sawada M; Ono Y; Fukushima M
Gan To Kagaku Ryoho; 2003 Feb; 30(2):289-92. PubMed ID: 12610881
[TBL] [Abstract][Full Text] [Related]
37. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
Bayrak R; Yenidünya S; Haltas H
Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
[TBL] [Abstract][Full Text] [Related]
38. Colonic-type adenocarcinoma arising in a primary retroperitoneal mature cystic teratoma.
Cheung WL; Cao D
Pathol Int; 2008 Dec; 58(12):792-6. PubMed ID: 19067855
[TBL] [Abstract][Full Text] [Related]
39. CDX-2 should be included in the work-up of patients with lung metastases from unknown primary.
Fazio N; De Pas T; de Braud F; Spaggiari L; Mazzarol G; Biffi R; Andreoni B; Zampino M; Curigliano G; Lorizzo K; Di Meglio G; Goldhirsch A
Ann Oncol; 2004 Dec; 15(12):1850. PubMed ID: 15550596
[No Abstract] [Full Text] [Related]
40. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes.
Choi HR; Sturgis EM; Rashid A; DeMonte F; Luna MA; Batsakis JG; El-Naggar AK
Hum Pathol; 2003 Nov; 34(11):1101-7. PubMed ID: 14652810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]